Skip to content

The association between atherogenic index of plasma and coronary heart disease in Chinese: A cross-sectional study

The association between atherogenic index of plasma and coronary heart disease in Chinese: A cross-sectional study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-16008502
Enrollment
Unknown
Registered
2016-05-20
Start date
2011-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHD

Interventions

Case series:NA

Sponsors

Central Hospital of Nanchong
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All subjects were from Nanchong, Sichuan province, P. R. China, and without a history of prior myocardial infarction or revascularization. The participants were consenting individuals undergoing coronary angiography at the Central Hospital of Nanchong in 2011–2014, and were at least 18 years of age. The indications for angiography included exercise-induced chest pain and atypical chest pain. Coronary angiograms were obtained by standard techniques, and multiple views were recorded. The angiograms were defined with respect to the number of vessels involved (0, 1, 2, or 3). According to the diagnostic criteria issued by the World Health Organization, in which at least one coronary stenosis = 50% should be present for CHD, a total of 229 patients were eligible. Those with a maximum stenosis of <10% in any artery were defined as control group.

Exclusion criteria

Exclusion criteria: Major exclusion criteria included whether they reported a history of coagulation disorders and familial hypercholesterolemia; New York Heart Association Class III and Class IV heart failure; ongoing systemic inflammatory diseases; renal or hepatic dysfunction; significant valvular disease, myocarditis, cardiomyopathies, and malignancy; or their unwillingness to participate in the survey.

Design outcomes

Primary

MeasureTime frame
atherogenic index of plasma;

Countries

China

Contacts

Public ContactTao Liu

Central Hospital of Nanchong

nclt456@sina.com+86 13990799928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026